Paperpal Prime Logo

EMBO Molecular Medicine : Impact Factor & More

eISSN: 1757-4684pISSN: 1757-4676
JournalOpen Access

Key Metrics

CiteScore
16.2
Eigenfactor
0.01 - 0.05
H-Index
130
Impact Factor
10 - 15
Scite Index
0.95 5-Year SI
SJR
Q1Molecular Medicine
SNIP
2.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on EMBO Molecular Medicine

EMBO Molecular Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesUSD 5000 | GBP 3960 | EUR 4500
Publication Time26
Editorial Review ProcessAnonymous peer review,Double anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEMBO
FrequencyMonthly
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 26
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review,Double anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in EMBO Molecular Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in EMBO Molecular Medicine

Dengue virus envelope epitope-specific antibodies are associated with protection from severe dengue.
  • 6 Aug 2026
  • EMBO molecular medicine
Deep visual multi-omics profiling links morphology and molecular programs in clear cell renal cell carcinoma.
  • 6 Aug 2026
  • EMBO molecular medicine
Reducing CETP activity prevents memory decline in an Alzheimer's disease mouse model.
  • 3 Aug 2026
  • EMBO molecular medicine
Inhibition of PGC1β-dependent mitochondrial biogenesis enhances EGFR-targeted therapy in lung cancer.
  • 30 Jul 2026
  • EMBO molecular medicine
Author Correction: Domain-substituted IGF2 tag modulates targeting of lentiviral gene therapy for Hunter syndrome.
  • 29 Jul 2026
  • EMBO molecular medicine
Abnormal ClC-3/TMEM9-mediated endosomal ion transport in CLCN3-associated neurodevelopmental disease.
  • 22 Jul 2026
  • EMBO molecular medicine
Dengue virus envelope epitope-specific antibodies are associated with protection from severe dengue.
  • 6 Aug 2026
  • EMBO molecular medicine
Deep visual multi-omics profiling links morphology and molecular programs in clear cell renal cell carcinoma.
  • 6 Aug 2026
  • EMBO molecular medicine
Reducing CETP activity prevents memory decline in an Alzheimer's disease mouse model.
  • 3 Aug 2026
  • EMBO molecular medicine
Inhibition of PGC1β-dependent mitochondrial biogenesis enhances EGFR-targeted therapy in lung cancer.
  • 30 Jul 2026
  • EMBO molecular medicine
Author Correction: Domain-substituted IGF2 tag modulates targeting of lentiviral gene therapy for Hunter syndrome.
  • 29 Jul 2026
  • EMBO molecular medicine
Abnormal ClC-3/TMEM9-mediated endosomal ion transport in CLCN3-associated neurodevelopmental disease.
  • 22 Jul 2026
  • EMBO molecular medicine

FAQs on EMBO Molecular Medicine